CD40LG and rheumatoid arthritis: Further analysis of the trajectory of anti-LtxA IgM antibodies from before onset of symptoms to established disease showed that the levels of anti-LtxA IgM were similar to controls during most of the pre-symptomatic stage and increased above controls before the start of symptomatic RA (Figure S1).